zinc finger protein 736 pseudogene 7, Y-linkedGenealiases: []
Q-omics provides the consensus-scored ZNF736P7Y profile across patient tissues and cancer cell-line models. ZNF736P7Y expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, ZNF736P7Y is differentially expressed in 1, with the highest sampling consensus in KIRC. Additionally, ZNF736P7Y RNA expression shows 2,682 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight KIRP, KIRC, and TGCT as cancer lineages where ZNF736P7Y shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ZNF736P7Y — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ZNF736P7Y survival associations across molecular data types. ZNF736P7Y RNA expression shows survival associations in the most cancer types (12). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ZNF736P7Y RNA expression–survival associations across cancer types. High ZNF736P7Y expression shows unfavorable associations in KIRP, SKCM, THCA, LIHC and MESO, but favorable associations in HNSC. The KIRP Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRP as the clearest survival context for ZNF736P7Y RNA expression.
This table summarizes ZNF736P7Y tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for ZNF736P7Y. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ZNF736P7Y shows higher tumor expression in KIRC. The KIRC box plot shows higher ZNF736P7Y RNA expression in tumor versus normal tissue (log2 FC = +0.016, t-test p = .009).
This table shows molecular features associated with ZNF736P7Y in patient tissues and cancer cell lines. In patient samples, ZNF736P7Y shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
